Office of Research & Development |
![]() ![]() |
Project Number: | I01CX001514-01A2 |
Title: | Novel Combination Therapy for Osteoporosis in Men |
Principal Investigator: | Dolores M. Shoback |
Location: | San Francisco, CA |
Congressional District Code: | 12 |
Research Service: | Clinical Science R&D |
Project Period: | July 2019 - June 2024 |
FY 2021 Funding Amount: | $50,000 |
Total Award Amount (all years): |
$1,000,000 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: In the US of the 1.5 million fractures that occur annually, one-third of them occur in men. Osteoporosis and fracture-related disability are key health problems in older male veterans. Fractures also increase mortality. Men who fracture their hips have twice the mortality of women sustaining those same hip fractures. Several drugs are approved to treat osteoporosis in men [bisphosphonates, denosumab, and teriparatide (TPTD) or PTH(1-34)], but we have little insight as to how to use them most eff... |